Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy
Description
CONCLUSION: Patients with post-COVID-19 conditions have enhanced vascular fibrosis and myosin light change phosphorylation. Rho-kinase activation represents a novel therapeutic target for clinical trials.
